Guangzhou Jointas Chemical Co., Ltd. (SHE:002909)
China · Delayed Price · Currency is CNY 6.77
+0.08 (1.20%)
May 6, 2026, 3:04 PM CST
SHE:002909 Income Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 |
Operating Revenue | 1,046 | 1,083 | 1,282 | 1,328 | 1,447 | 1,674 |
Other Revenue | 3.04 | 3.04 | 3.05 | 3.92 | 3.59 | 1.56 |
| 1,049 | 1,086 | 1,285 | 1,332 | 1,450 | 1,676 | |
Revenue Growth (YoY) | -19.40% | -15.50% | -3.56% | -8.13% | -13.44% | 33.12% |
Cost of Revenue | 782.53 | 810.3 | 962.42 | 999.44 | 1,139 | 1,324 |
Gross Profit | 266.71 | 275.41 | 322.49 | 332.96 | 311.27 | 351.55 |
Selling, General & Admin | 203.17 | 200.61 | 199.83 | 219.44 | 198.6 | 202.94 |
Research & Development | 48.24 | 49.36 | 59.3 | 65.02 | 60.56 | 68.87 |
Other Operating Expenses | 6.48 | 6.16 | 4.65 | 2.11 | 8.46 | 8.34 |
Operating Expenses | 277.41 | 275.66 | 282.16 | 294.73 | 285.98 | 293.88 |
Operating Income | -10.7 | -0.25 | 40.33 | 38.23 | 25.29 | 57.68 |
Interest Expense | -23.76 | -23.76 | -28.46 | -29.17 | -24.82 | -16.47 |
Interest & Investment Income | 0.25 | 0.25 | 0.88 | 1.74 | 2.88 | 4.78 |
Currency Exchange Gain (Loss) | -0.19 | -0.19 | 0.11 | 0.16 | 0.78 | 0.12 |
Other Non Operating Income (Expenses) | 1.16 | -1.41 | -1.37 | -0.85 | -0.84 | -1.34 |
EBT Excluding Unusual Items | -33.15 | -25.36 | 11.48 | 10.11 | 3.29 | 44.77 |
Gain (Loss) on Sale of Investments | 11.48 | 11.46 | -0.62 | - | 3.08 | - |
Gain (Loss) on Sale of Assets | -0.02 | 0.02 | 0.1 | 0.1 | 0.06 | -0.96 |
Asset Writedown | -16.4 | -15.85 | -2.34 | -0.49 | -0.8 | -0.49 |
Other Unusual Items | 0.59 | 0.59 | 3.94 | 1.43 | 5.98 | 10.5 |
Pretax Income | -37.5 | -29.14 | 12.56 | 11.15 | 11.61 | 53.82 |
Income Tax Expense | -1.68 | -0.67 | -6.71 | 0.9 | 1.41 | 3.12 |
Earnings From Continuing Operations | -35.81 | -28.47 | 19.27 | 10.25 | 10.2 | 50.7 |
Minority Interest in Earnings | 0.76 | 0.74 | 0.01 | -0.01 | -0 | -0.01 |
Net Income | -35.06 | -27.73 | 19.28 | 10.24 | 10.19 | 50.69 |
Net Income to Common | -35.06 | -27.73 | 19.28 | 10.24 | 10.19 | 50.69 |
Net Income Growth | - | - | 88.27% | 0.49% | -79.90% | -54.64% |
Shares Outstanding (Basic) | 384 | 385 | 393 | 379 | 377 | 373 |
Shares Outstanding (Diluted) | 384 | 385 | 393 | 379 | 377 | 373 |
Shares Change (YoY) | -2.15% | -2.12% | 3.74% | 0.49% | 1.27% | 14.06% |
EPS (Basic) | -0.09 | -0.07 | 0.05 | 0.03 | 0.03 | 0.14 |
EPS (Diluted) | -0.09 | -0.07 | 0.05 | 0.03 | 0.03 | 0.14 |
EPS Growth | - | - | 81.48% | - | -80.15% | -60.23% |
Free Cash Flow | -104.4 | -141.05 | 90.82 | -11.52 | -304.09 | -113.21 |
Free Cash Flow Per Share | -0.27 | -0.37 | 0.23 | -0.03 | -0.81 | -0.30 |
Dividend Per Share | - | - | 0.100 | 0.050 | 0.050 | 0.050 |
Dividend Growth | - | - | 100.00% | - | - | -53.31% |
Gross Margin | 25.42% | 25.37% | 25.10% | 24.99% | 21.46% | 20.98% |
Operating Margin | -1.02% | -0.02% | 3.14% | 2.87% | 1.74% | 3.44% |
Profit Margin | -3.34% | -2.55% | 1.50% | 0.77% | 0.70% | 3.02% |
Free Cash Flow Margin | -9.95% | -12.99% | 7.07% | -0.86% | -20.97% | -6.76% |
EBITDA | 65.4 | 72.24 | 98.37 | 92.68 | 69.58 | 92.44 |
EBITDA Margin | 6.23% | 6.65% | 7.66% | 6.96% | 4.80% | 5.52% |
D&A For EBITDA | 76.1 | 72.49 | 58.04 | 54.45 | 44.29 | 34.76 |
EBIT | -10.7 | -0.25 | 40.33 | 38.23 | 25.29 | 57.68 |
EBIT Margin | -1.02% | -0.02% | 3.14% | 2.87% | 1.74% | 3.44% |
Effective Tax Rate | - | - | - | 8.11% | 12.17% | 5.81% |
Revenue as Reported | 1,086 | 1,086 | 1,285 | 1,332 | 1,450 | 1,676 |
Advertising Expenses | - | 2.14 | 5.72 | 12.57 | 5.99 | 5.96 |
Source: S&P Global Market Intelligence. Standard template. Financial Sources.